XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional paid-in capital
Treasury stock
Accumulated other comprehensive loss
Accumulated deficit
Public Offering
Balance at Dec. 31, 2021 $ 80,674 $ 10 $ 892,828 $ (25,097) $ (6,036) $ (781,031)  
Balance, shares at Dec. 31, 2021   99,537          
Stock-based compensation 7,730   7,730        
Sales agent equity incentives 2,178   2,178        
Sales agent equity incentives, shares   199          
Common stock issued for warrant exercises 1,289   1,289        
Common stock issued for warrant exercises, shares   551          
Common stock issued for stock option exercises 140   140        
Common stock issued for stock option exercises, shares   39          
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (4,751)   (4,751)        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   852          
Foreign currency translation adjustments (1,204)       (1,204)    
Net loss (42,616)         (42,616)  
Balance at Mar. 31, 2022 43,440 $ 10 899,414 (25,097) (7,240) (823,647)  
Balance, shares at Mar. 31, 2022   101,178          
Balance at Dec. 31, 2021 80,674 $ 10 892,828 (25,097) (6,036) (781,031)  
Balance, shares at Dec. 31, 2021   99,537          
Foreign currency translation adjustments (11,550)            
Net loss (116,510)            
Balance at Sep. 30, 2022 (20,894) $ 11 919,319 (25,097) (17,586) (897,541)  
Balance, shares at Sep. 30, 2022   104,984          
Balance at Mar. 31, 2022 43,440 $ 10 899,414 (25,097) (7,240) (823,647)  
Balance, shares at Mar. 31, 2022   101,178          
Stock-based compensation 10,109   10,109        
Sales agent equity incentives 361   361        
Sales agent equity incentives, shares   20          
Common stock issued for conversion of Series A preferred stock   29          
Common stock issued for warrant exercises 2,675 $ 1 2,674        
Common stock issued for warrant exercises, shares   1,914          
Common stock issued for employee stock purchase plan and stock option exercises, shares   535          
Common stock issued for employee stock purchase plan and stock option exercises 2,331   2,331        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (4,562)   (4,562)        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   819          
Common stock issued for asset acquisition 250   250        
Common stock issued for asset acquisition, shares   23          
Foreign currency translation adjustments (5,388)       (5,388)    
Net loss (37,101)         (37,101)  
Balance at Jun. 30, 2022 12,115 $ 11 910,577 (25,097) (12,628) (860,748)  
Balance, shares at Jun. 30, 2022   104,518          
Stock-based compensation 10,011   10,011        
Sales agent equity incentives 178   178        
Common stock issued for warrant exercises 196   196        
Common stock issued for warrant exercises, shares   49          
Common stock issued for employee stock purchase plan and stock option exercises, shares   11          
Common stock issued for employee stock purchase plan and stock option exercises 47   47        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (1,690)   (1,690)        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   406          
Foreign currency translation adjustments (4,958)       (4,958)    
Net loss (36,793)         (36,793)  
Balance at Sep. 30, 2022 (20,894) $ 11 919,319 (25,097) (17,586) (897,541)  
Balance, shares at Sep. 30, 2022   104,984          
Balance at Dec. 31, 2022 (34,667) $ 11 933,537 (25,097) (10,794) (932,324)  
Balance, shares at Dec. 31, 2022   106,640          
Stock-based compensation 16,462   16,462        
Common stock issued for warrant exercises 457 $ 1 456        
Common stock issued for warrant exercises, shares   4,443          
Common stock issued for stock option exercises 768   768        
Common stock issued for stock option exercises, shares   349          
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (2,331)   (2,331)        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   2,027          
Reclassification of equity-based liability 3,373   3,373        
Foreign currency translation adjustments 1,105       1,105    
Net loss (43,529)         (43,529)  
Balance at Mar. 31, 2023 (58,362) $ 12 952,265 (25,097) (9,689) (975,853)  
Balance, shares at Mar. 31, 2023   113,459          
Balance at Dec. 31, 2022 (34,667) $ 11 933,537 (25,097) (10,794) (932,324)  
Balance, shares at Dec. 31, 2022   106,640          
Foreign currency translation adjustments (1,317)            
Net loss (137,560)            
Balance at Sep. 30, 2023 (44,161) $ 12 1,062,919 (25,097) (12,111) (1,069,884)  
Balance, shares at Sep. 30, 2023   123,311          
Balance at Mar. 31, 2023 (58,362) $ 12 952,265 (25,097) (9,689) (975,853)  
Balance, shares at Mar. 31, 2023   113,459          
Stock-based compensation 24,194   24,194        
Common stock issued for warrant exercises 172   $ 172        
Common stock issued for warrant exercises, shares   1,121          
Common stock issued for employee stock purchase plan and stock option exercises, shares   274 2,277        
Common stock issued for employee stock purchase plan and stock option exercises $ 2,277            
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares (2,934) 2,711 (2,934)        
Common stock offering, net of offering costs     $ 57,511       $ 57,511
Common stock offering, net of offering costs, shares   4,286          
Reclassification of equity-based liability $ 188   188        
Foreign currency translation adjustments 178       178    
Net loss (51,377)         (51,377)  
Balance at Jun. 30, 2023 (28,153) $ 12 1,033,673 (25,097) (9,511) (1,027,230)  
Balance, shares at Jun. 30, 2023   121,851          
Stock-based compensation 20,073   20,073        
Common stock issued for stock option exercises 38   38        
Common stock issued for stock option exercises, shares   8          
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (782)   (782)        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   784          
Common stock offering, net of offering costs 9,917   9,917        
Common stock offering, net of offering costs, shares   668          
Foreign currency translation adjustments (2,600)       (2,600)    
Net loss (42,654)         (42,654)  
Balance at Sep. 30, 2023 $ (44,161) $ 12 $ 1,062,919 $ (25,097) $ (12,111) $ (1,069,884)  
Balance, shares at Sep. 30, 2023   123,311